Correction to: Oncogene https://doi.org/10.1038/onc.2015.377, published online 07 December 2015
Following the publication of this article, the authors have identified incorrect images in Figure 3d (Ki67, Dox On) and Figure 4b (p-ERK). Updated versions with the correct images are provided below.
The authors confirm that these corrections do not affect the study’s results, interpretations, or conclusions. We sincerely apologize for these unintentional errors and any inconvenience they may have caused. The original article has been corrected.
Figure 3
Figure 4
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cheng, H., Liu, P., Ohlson, C. et al. Correction: PIK3CAH1047R- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling. Oncogene 44, 478–479 (2025). https://doi.org/10.1038/s41388-025-03281-8
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41388-025-03281-8
This article is cited by
-
Beyond borders: engineering organ-targeted immunotherapies to overcome site-specific barriers in cancer
Drug Delivery and Translational Research (2025)
